Value through Innovation11 February 2016

Image Gallery - Stroke Prevention in AF

The information contained in the terms and conditions of use applies to texts, photos and diagrams. If used, the following acknowledgement is required in accordance with copyright law: “Copyright: Boehringer Ingelheim”. If published, please provide a specimen copy.

Atrial fibrillation (AF) is the most common sustained heart rhythm condition and raises the risk of stroke by five times.

One in four adults over 40 will develop atrial fibrillation in their lifetime.
In Europe alone, 4,5 million people are affected.

Most cases of stroke caused by atrial fibrillation can be prevented by means of an anticoagulant therapy based on guidelines.

Three million patients worldwide suffer AF-related strokes each year, which tend to be especially severe and disabling with half of the people dying within one year.

Working in partnership with your doctor is a very important factor in making sure your health is as well protected as possible.

The most important examination for confirmation of an atrial fibrillation is electrocardiographic monitoring (ECG) which measures the electronic activity of the heart muscle.